TELO

Zacks Small Cap Analysis – TELO Reverses Injury in Progeria Cells – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescribed drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm creating a product designed to reverse organic growing older and degenerative ailments. Beforehand reported preclinical exams have proven proof that Telomir-1, the corporate’s major remedy, can lengthen telomeres and preliminary animal testing illustrates the … Read more

Zacks Small Cap Analysis – TELO Continues Development of Important Trial Bulletins – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescribed drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm growing a product designed to reverse organic getting older and degenerative ailments. Beforehand reported preclinical exams have proven proof that Telomir-1, the corporate’s major remedy, can lengthen telomeres and preliminary animal testing illustrates the … Read more

Zacks Small Cap Analysis – TELO Produces Outcomes with Thrilling AMD Implications – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescription drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm growing a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical checks have proven proof that Telomir-1, the corporate’s main remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more

Zacks Small Cap Analysis – TELO Declares Promising Getting older Reversal Check Outcomes – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescription drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm creating a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical assessments have proven proof that Telomir-1, the corporate’s major remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more

x